DiaMedica Therapeutics (DMAC) Net Shares Issued and Repurchased (2017 - 2026)

DiaMedica Therapeutics (DMAC) has reported Net Shares Issued and Repurchased for 10 consecutive years, with $377122.0 the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Net Shares Issued and Repurchased fell 90.72% year-over-year to $377122.0; the trailing twelve-month figure through Mar 2026 stood at $377122.0 (down 90.72% YoY), and the FY2025 full-year result was $3.4 million, up 84.12% from the prior year.
• Net Shares Issued and Repurchased fell to $377122.0 in Q1 2026 per DMAC's latest filing, from $3.4 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $4.1 million in Q1 2025 and bottomed at $8750.0 in Q1 2023.
• Historically, Net Shares Issued and Repurchased has averaged $1.5 million across 5 years, with a median of $1.2 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Net Shares Issued and Repurchased slumped 99.36% in 2023, then jumped 4871.43% in 2024.
• Over 5 years, Net Shares Issued and Repurchased stood at $1.0 million in 2022, then advanced by 15.59% to $1.2 million in 2023, then surged by 59.04% to $1.9 million in 2024, then surged by 84.12% to $3.4 million in 2025, then plunged by 89.02% to $377122.0 in 2026.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $377122.0, $3.4 million, and $4.1 million for Q1 2026, Q4 2025, and Q1 2025 respectively.